Outlook Therapeutics, Inc.
OTLK
$2.41
-$0.2901-10.74%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 17.79% | 32.51% | -61.80% | -53.39% | -32.19% |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | 14.49% | 15.92% | -- | -- | -- |
Prepaid Expenses | -4.95% | -3.05% | -45.11% | -8.13% | 28.76% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 18.47% | 13.66% | -42.85% | -39.90% | -21.06% |
|
|||||
Total Current Assets | 18.47% | 13.66% | -42.85% | -39.90% | -21.06% |
Net Property, Plant & Equipment | -4.95% | -4.60% | -4.30% | -4.15% | 7,643.24% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 17.93% | -5.34% | -5.30% | -8.33% | 1.27% |
Total Assets | 17.39% | 12.17% | -41.00% | -38.79% | -20.22% |
|
|||||
Total Accounts Payable | 32.14% | -36.31% | 53.01% | 43.52% | 27.26% |
Total Accrued Expenses | 68.95% | -7.25% | 4.75% | 20.76% | -13.95% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 16.61% | -60.86% | 4.43% | -9.16% | -27.45% |
Total Finance Division Other Current Liabilities | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Total Other Current Liabilities | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Total Current Liabilities | 26.86% | -48.54% | 13.36% | 0.00% | -21.31% |
|
|||||
Total Current Liabilities | 26.86% | -48.54% | 13.36% | 0.00% | -21.31% |
Long-Term Debt | -2.89% | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -6.80% | -6.05% | -5.59% | -5.18% | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 36.68% | -71.04% | -68.14% | -32.80% | -36.81% |
Total Liabilities | 15.61% | -23.42% | -33.96% | -22.07% | -32.34% |
|
|||||
Common Stock & APIC | 2.86% | 13.50% | 1.15% | 1.05% | 1.34% |
Retained Earnings | -3.52% | -8.81% | 3.20% | 1.04% | 7.48% |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | -14.56% | 35.45% | 31.18% | 12.66% | 37.67% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -14.56% | 35.45% | 31.18% | 12.66% | 37.67% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -14.56% | 35.45% | 31.18% | 12.66% | 37.67% |
|